CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model

Hong Wan; Xiaowei Yang; Guopeng Sang; Zhifan Ruan; Zichen Ling; Mingzhao Zhang; Chang Liu; Xiangyang Hu; Tao Guo; Juntong He; Defeng Liu; Jing Pei

doi:doi:10.18632/aging.205125

← Back

Research Paper Volume 15, Issue 20 pp 11244—11267

CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model

Figure 8. Expression profiles and prognosis features of CRG subgroups. (A) Expression profile of 10 CRGs in CRGs. (B) Prognosis differences of CRG subgroups. (C) CRG subgroup division identified the prognosis differences in single cancers, including CESC, HNSC, KICH, KIRC, LGG, LIHC, LUAD, MESO, READ, SARC, UCEC, and UCS.